Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note released on Thursday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.6 % NASDAQ:LPCN opened at $0.29 on Thursday. The firm has a fifty day simple moving average of $0.40 and a […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research report report published on Wednesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance LPCN stock opened at $0.32 on Wednesday. Lipocine has a twelve month low of $0.27 and a twelve month high of […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Monday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 5.4 % Lipocine stock opened at $0.31 on Monday. The firm has a 50-day moving average of $0.47 and a 200-day […]